Citation:Horn L, Bernardo P, Sandler A, Wagner H, Levitan N, Levitt ML, et al 2009

Citation

Horn L, Bernardo P, Sandler A, Wagner H, Levitan N, Levitt ML, et al. A phase II study of paclitaxel + etoposide + cisplatin + concurrent radiation therapy for previously untreated limited stage small cell lung cancer (E2596): a trial of the Eastern Cooperative Oncology Group. J Thorac Oncol 2009 Apr;4(4):527-33 Available from: http://www.ncbi.nlm.nih.gov/pubmed/19240650.

Critical appraisals

• Assign a critical appraisal

Critical appraisal link	Clinical question	Assigned to	Status
Horn L, Bernardo P, Sandler A, Wagner H, Levitan N, Levitt ML, et al 2009	What is the optimal concurrent chemotherapy to be used for the treatment of limited stage small cell lung cancer with radiotherapy?	Associate Professor Michael Michael MBBS(Hons), BSc(Hons), MD, FRACP	completed

Compare quality appraisals for each clinical question

• [[Clinical question:What is the optimal concurrent chemotherapy to be used for the treatment of limited stage small cell lung cancer with radiotherapy?|]] (compare critical appraisals)

Cited by

1. What is the optimal concurrent chemotherapy to be used for the treatment of limited stage small cell lung cancer with radiotherapy?